Therapy Detail

Therapy Name D-0502
Synonym
Therapy Description

D-0502 is a selective estrogen receptor degrader (SERD) that prevents cell proliferation of ER-positive cells (AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5776).

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Drug Name Trade Name Synonyms Drug Classes Drug Description
D-0502 Hormone - Anti-androgens 22 D-0502 is a selective estrogen receptor degrader (SERD) that prevents cell proliferation of ER-positive cells (AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5776).
Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
Clinical Trial Phase Therapies Title Recruitment Status
NCT03471663 Phase I D-0502 + Palbociclib D-0502 A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer Recruiting